{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T17:34:20Z","timestamp":1792863260931,"version":"4.5.0"},"reference-count":174,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T00:00:00Z","timestamp":1667088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Carlos III Health Institute","award":["PI20\/01258"],"award-info":[{"award-number":["PI20\/01258"]}]},{"name":"Spanish Association for Study of the Liver","award":["PI20\/01258"],"award-info":[{"award-number":["PI20\/01258"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Portal vein thrombosis constitutes the most common thrombotic event in patients with cirrhosis, with increased rates in the setting of advanced liver disease. Despite being a well-known complication of cirrhosis, the contribution of portal vein thrombosis to hepatic decompensation and overall mortality is still a matter of debate. The incorporation of direct oral anticoagulants and new radiological techniques for portal vein recanalization have expanded our therapeutic arsenal. However, the lack of large prospective observational studies and randomized trials explain the heterogenous diagnostic and therapeutic recommendations of current guidelines. This article seeks to make a comprehensive review of the pathophysiology, clinical features, diagnosis, and treatment of portal vein thrombosis in patients with cirrhosis.<\/jats:p>","DOI":"10.3390\/jcm11216435","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T07:26:50Z","timestamp":1667114810000},"page":"6435","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive Review"],"prefix":"10.3390","volume":"11","author":[{"given":"Aitor","family":"Odriozola","sequence":"first","affiliation":[{"name":"Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqu\u00e9s de Valdecilla University Hospital, 39008 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Puente","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqu\u00e9s de Valdecilla University Hospital, 39008 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1363-864X","authenticated-orcid":false,"given":"Antonio","family":"Cuadrado","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqu\u00e9s de Valdecilla University Hospital, 39008 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coral","family":"Rivas","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqu\u00e9s de Valdecilla University Hospital, 39008 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Anton","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqu\u00e9s de Valdecilla University Hospital, 39008 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Jos\u00e9","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Radiology Department, Marqu\u00e9s de Valdecilla University Hospital, 39008 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Pell\u00f3n","sequence":"additional","affiliation":[{"name":"Radiology Department, Marqu\u00e9s de Valdecilla University Hospital, 39008 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1876-3973","authenticated-orcid":false,"given":"Emilio","family":"F\u00e1brega","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqu\u00e9s de Valdecilla University Hospital, 39008 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8248-0172","authenticated-orcid":false,"given":"Javier","family":"Crespo","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqu\u00e9s de Valdecilla University Hospital, 39008 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ignacio","family":"Fortea","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqu\u00e9s de Valdecilla University Hospital, 39008 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2016). EASL Clinical Practice Guidelines: Vascular diseases of the liver. J. Hepatol., 64, 179\u2013202.","DOI":"10.1016\/j.jhep.2015.07.040"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.14309\/ajg.0000000000000486","article-title":"ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation","volume":"115","author":"Simonetto","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - Renewing consensus in portal hypertension","volume":"76","author":"Bosch","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_5","first-page":"2364","article-title":"Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: Results of a case-control study","volume":"96","author":"Janssen","year":"2000","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/gut.49.5.720","article-title":"Extrahepatic portal vein thrombosis: Aetiology and determinants of survival","volume":"49","author":"Janssen","year":"2001","journal-title":"Gut"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Sogaard, K.K., Astrup, L.B., Vilstrup, H., and Gronbaek, H. (2007). Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol., 7.","DOI":"10.1186\/1471-230X-7-34"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0016-5085(88)90567-7","article-title":"Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders","volume":"94","author":"Valla","year":"1988","journal-title":"Gastroenterol."},{"key":"ref_9","first-page":"538","article-title":"Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver","volume":"40","author":"Albillos","year":"2017","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_10","first-page":"1491","article-title":"faculty of the 7th International Coagulation in Liver D. Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference","volume":"118","author":"Intagliata","year":"2018","journal-title":"Thromb. Haemost."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2019.03.070","article-title":"AGA Clinical Practice Update: Coagulation in Cirrhosis","volume":"157","author":"Greenberg","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/jth.14836","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation","volume":"18","author":"Valeriani","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Fortea, J.I., Puente, \u00c1., Cuadrado, A., Huelin, P., Pell\u00f3n, R., Gonz\u00e1lez S\u00e1nchez, F.J., Mayorga, M., Cagigal, M.L., Carrera, I.G., and Cobreros, M. (2020). Congestive Hepatopathy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249420"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1055\/s-0031-1281745","article-title":"Depiction of variants of the portal confluence venous system using multidetector row CT: Analysis of 916 cases","volume":"183","author":"Krumm","year":"2011","journal-title":"Rofo"},{"key":"ref_15","first-page":"1667","article-title":"Variation of the intrahepatic portal vein; angiographic demonstration and application in living-related hepatic transplantation","volume":"28","author":"Cheng","year":"1996","journal-title":"Transplant. Proc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/00007890-200005150-00023","article-title":"Portal vein thrombosis in adults undergoing liver transplantation: Risk factors, screening, management, and outcome","volume":"69","author":"Yerdel","year":"2000","journal-title":"Transplantation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/lt.20869","article-title":"The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis","volume":"12","author":"Bauer","year":"2006","journal-title":"Liver Transplant."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1053\/j.gastro.2016.08.033","article-title":"Toward a Comprehensive New Classification of Portal Vein Thrombosis in Patients with Cirrhosis","volume":"151","author":"Sarin","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2019.08.012","article-title":"Novel classification of non-malignant portal vein thrombosis: A guide to surgical decision-making during liver transplantation","volume":"71","author":"Bhangui","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hep.23259","article-title":"Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow-up study","volume":"51","author":"Plessier","year":"2010","journal-title":"Hepatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1478-3231.2012.02785.x","article-title":"Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis","volume":"32","author":"Senzolo","year":"2012","journal-title":"Liver Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3109\/00365521.2012.674972","article-title":"Emergency anticoagulation treatment for cirrhosis patients with portal vein thrombosis and acute variceal bleeding","volume":"47","author":"Maruyama","year":"2012","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2214\/ajr.165.5.7572494","article-title":"Cavernous transformation of the portal vein: Patterns of intrahepatic and splanchnic collateral circulation detected with Doppler sonography","volume":"165","author":"Lafortune","year":"1995","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Anton, A., Campreci\u00f3s, G., P\u00e9rez-Campuzano, V., Orts, L., Garc\u00eda-Pag\u00e1n, J.C., and Hern\u00e1ndez-Gea, V. (2022). The Pathophysiology of Portal Vein Thrombosis in Cirrhosis: Getting Deeper into Virchow\u2019s Triad. J. Clin. Med., 11.","DOI":"10.3390\/jcm11030800"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jhep.2009.03.013","article-title":"Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development","volume":"51","author":"Zocco","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/MEG.0000000000000325","article-title":"De-novo portal vein thrombosis in liver cirrhosis: Risk factors and correlation with the Model for End-stage Liver Disease scoring system","volume":"27","author":"Mousa","year":"2015","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/liv.13500","article-title":"Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case-control study","volume":"38","author":"Stine","year":"2018","journal-title":"Liver Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jhep.2021.07.020","article-title":"Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors","volume":"75","author":"Turon","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.27546","article-title":"Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: Results of a longitudinal study","volume":"61","author":"Nery","year":"2015","journal-title":"Hepatology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ajg.2012.452","article-title":"De novo portal vein thrombosis in virus-related cirrhosis: Predictive factors and long-term outcomes","volume":"108","author":"Maruyama","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.21037\/atm-20-4912","article-title":"Increased portal vein diameter is predictive of portal vein thrombosis development in patients with liver cirrhosis","volume":"9","author":"Dong","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/gut.2010.228023","article-title":"Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis","volume":"60","author":"Luca","year":"2011","journal-title":"Gut"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/apt.15137","article-title":"Nonselective beta-blockers and the risk of portal vein thrombosis in patients with cirrhosis: Results of a prospective longitudinal study","volume":"49","author":"Nery","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1007\/s12325-020-01250-z","article-title":"Nonselective \u03b2-Blockers May Progress the Thrombosis of Portal Venous System in Cirrhotic Patients: A Retrospective Observational Study","volume":"37","author":"Xu","year":"2020","journal-title":"Adv. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s12072-019-09951-6","article-title":"Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis","volume":"13","author":"Xu","year":"2019","journal-title":"Hepatol. Int."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"EASL (2022). Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. J. Hepatol., 76, 1151\u20131184.","DOI":"10.1016\/j.jhep.2021.09.003"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhepr.2019.02.006","article-title":"Anticoagulation in the cirrhotic patient","volume":"1","author":"Turco","year":"2019","journal-title":"JHEP Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1053\/j.gastro.2009.08.045","article-title":"An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis","volume":"137","author":"Tripodi","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2021.12.038","article-title":"Factor VIII\/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD","volume":"76","author":"Scheiner","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/hep.28703","article-title":"High von Willebrand factor antigen levels and procoagulant imbalance may be involved in both increasing severity of cirrhosis and portal vein thrombosis","volume":"64","author":"Kalambokis","year":"2016","journal-title":"Hepatology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1076029620982666","DOI":"10.1177\/1076029620982666","article-title":"Evaluation of Coagulation, Fibrinolysis and Endothelial Biomarkers in Cirrhotic Patients With or Without Portal Venous Thrombosis","volume":"26","author":"Ren","year":"2020","journal-title":"Clin. Appl Thromb. Hemost."},{"key":"ref_42","unstructured":"Zanetto, A., Pelizzaro, F., Campello, E., Bulato, C., Balcar, L., Gu, W., Gavasso, S., Saggiorato, G., Zeuzem, S., and Russo, F.P. (2022). Severity of systemic inflammation is the main predictor of ACLF and bleeding in patients with acutely decompensated cirrhosis. J. Hepatol., S0168-8278(22)03110-5."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1160\/TH10-01-0040","article-title":"Comparative study of coagulation and thrombin generation in the portal and jugular plasma of patients with cirrhosis","volume":"104","author":"Delahousse","year":"2010","journal-title":"Thromb. Haemost."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e00123","DOI":"10.14309\/ctg.0000000000000123","article-title":"Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein Thrombosis","volume":"11","author":"Praktiknjo","year":"2020","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/jth.15797","article-title":"The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study","volume":"20","author":"Driever","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1080\/09537104.2022.2060499","article-title":"Reply to \u201cPeripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis\u201d","volume":"33","author":"Shalaby","year":"2022","journal-title":"Platelets"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jhep.2022.03.009","article-title":"Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death","volume":"77","author":"Zanetto","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Quan, X., Ye, X., Qian, S., Wei, B., Tong, H., Wang, Z., Tai, Y., Guo, X., Gao, J., and Wu, H. (2022). Portal vein thrombosis associates with high platelet-fibrin clot strength and platelet activation in decompensated cirrhosis: A retrospective study. Dig. Liver Dis.","DOI":"10.1016\/j.dld.2022.09.019"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Zanetto, A., Campello, E., Burra, P., Senzolo, M., and Simioni, P. (2022). Increased platelet ratio in patients with decompensated cirrhosis indicates higher risk of portal vein thrombosis. Liver Int.","DOI":"10.1016\/S0168-8278(22)01072-8"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Sacco, M., Tardugno, M., Lancellotti, S., Ferretti, A., Ponziani, F.R., Riccardi, L., Zocco, M.A., De Magistris, A., Santopaolo, F., and Pompili, M. (2022). ADAMTS-13\/von Willebrand factor ratio: A prognostic biomarker for portavein thrombosis in compensated cirrhosis. A prospective observational study. Dig. Liver Dis., S1590-8658(22)00543-6.","DOI":"10.1016\/j.dld.2022.06.004"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jhep.2020.11.048","article-title":"The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis","volume":"74","author":"Arroyo","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/liv.15183","article-title":"Haemostatic alterations in patients with cirrhosis and hepatocellular carcinoma: Laboratory evidence and clinical implications","volume":"42","author":"Zanetto","year":"2022","journal-title":"Liver Int."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/hep4.1317","article-title":"Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis","volume":"3","author":"Basili","year":"2019","journal-title":"Hepatol. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): An open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jhep.2018.08.006","article-title":"Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial","volume":"69","author":"Castellote","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/gut.40.6.798","article-title":"Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis","volume":"40","author":"Mahmoud","year":"1997","journal-title":"Gut"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2004.01.001","article-title":"Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis","volume":"40","author":"Amitrano","year":"2004","journal-title":"J. Hepatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/hep.510310213","article-title":"Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis","volume":"31","author":"Amitrano","year":"2000","journal-title":"Hepatology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1160\/TH05-08-0555","article-title":"Increased plasma prothrombin concentration in cirrhotic patients with portal vein thrombosis and prothrombin G20210A mutation","volume":"95","author":"Amitrano","year":"2006","journal-title":"Thromb. Haemost."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/1076029610369797","article-title":"Antiphospholipid antibodies and antiphospholipid syndrome: Role in portal vein thrombosis in patients with and without liver cirrhosis","volume":"17","author":"Amitrano","year":"2011","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00042737-200507000-00009","article-title":"Causes of portal venous thrombosis in cirrhotic patients: The role of genetic and acquired factors","volume":"17","author":"Mangia","year":"2005","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1478-3231.2005.01215.x","article-title":"MTHFR C677T mutations in liver cirrhosis with and without portal vein thrombosis","volume":"26","author":"Pasta","year":"2006","journal-title":"Liver Int."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jceh.2015.11.002","article-title":"PAI-1 4G-4G, MTHFR 677TT, V Leiden 506Q, and Prothrombin 20210A in Splanchnic Vein Thrombosis: Analysis of Individual Patient Data from Three Prospective Studies","volume":"6","author":"Pasta","year":"2016","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/MEG.0b013e3282f1cff7","article-title":"Janus kinase-2 mutation, cirrhosis and splanchnic vein thrombosis","volume":"20","author":"Colaizzo","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1872-034X.2010.00628.x","article-title":"Portal vein thrombosis in Egyptian patients with liver cirrhosis: Role of methylenetetrahydrofolate reductase C677T gene mutation","volume":"40","author":"Gabr","year":"2010","journal-title":"Hepatol. Res."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Ayala, R., Grande, S., Bustelos, R., Ribera, C., Garc\u00eda-Sesma, A., Jimenez, C.A., Moreno, E., and Mart\u00ednez-L\u00f3pez, J. (2012). Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients. BMC Gastroenterol., 12.","DOI":"10.1186\/1471-230X-12-114"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1440-1746.2011.07040.x","article-title":"Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: A prospective study","volume":"27","author":"Qi","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s10620-012-2548-y","article-title":"Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: Outcome of anticoagulation","volume":"58","author":"Werner","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5152\/tjg.2015.5738","article-title":"Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and\/or portal vein thrombosis","volume":"26","author":"Karakose","year":"2015","journal-title":"Turk. J. Gastroenterol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11239-014-1124-z","article-title":"Thrombophilic factor analysis in cirrhotic patients with portal vein thrombosis","volume":"40","author":"Saugel","year":"2015","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s11739-016-1467-x","article-title":"Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: A pilot study","volume":"11","author":"Lancellotti","year":"2016","journal-title":"Intern. Emerg. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.thromres.2016.03.024","article-title":"Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosis","volume":"141","author":"Ventura","year":"2016","journal-title":"Thromb. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.gastrohep.2018.06.005","article-title":"Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis","volume":"41","author":"Artaza","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41424-018-0043-2","article-title":"Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis","volume":"9","author":"Senzolo","year":"2018","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_75","first-page":"3189","article-title":"The risk factors of portal vein thrombosis in patients with liver cirrhosis","volume":"17","author":"Cagin","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/MBC.0000000000000901","article-title":"The utility of thrombophilia testing in patients with newly diagnosed portal vein thrombosis","volume":"31","author":"Tremblay","year":"2020","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Fortea, J.I., Carrera, I.G., Puente, \u00c1., Cuadrado, A., Huelin, P., Tato, C., Fern\u00e1ndez, P., Montes, M.D.R.P., C\u00e9spedes, J.N., and L\u00f3pez, A.B. (2020). Portal Thrombosis in Cirrhosis: Role of Thrombophilic Disorders. J. Clin. Med., 9.","DOI":"10.3390\/jcm9092822"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1160\/TH07-08-0526","article-title":"Inherited thrombophilic abnormalities and risk of portal vein thrombosis. a meta-analysis","volume":"99","author":"Dentali","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.cgh.2014.04.026","article-title":"Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: A systematic review and meta-analysis","volume":"12","author":"Qi","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/rth2.12253","article-title":"Inherited thrombophilia and portal vein thrombosis in cirrhosis: A systematic review and meta-analysis","volume":"3","author":"Ma","year":"2019","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MAJ.0b013e31826485fc","article-title":"Effect of antithrombin, protein C and protein S on portal vein thrombosis in liver cirrhosis: A meta-analysis","volume":"346","author":"Qi","year":"2013","journal-title":"Am. J. Med. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s11239-020-02090-y","article-title":"Thrombophilia screening revisited: An issue of personalized medicine","volume":"49","author":"Colucci","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1053\/j.gastro.2019.01.265","article-title":"Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients with and without Cirrhosis","volume":"156","author":"Intagliata","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jceh.2021.11.003","article-title":"Portal Vein Thrombosis in Cirrhosis","volume":"12","author":"Shukla","year":"2022","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/liv.14121","article-title":"Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study","volume":"39","author":"Marinho","year":"2019","journal-title":"Liver Int."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-0038-1676981","article-title":"Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients","volume":"119","author":"Violi","year":"2019","journal-title":"Thromb. Haemost."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejim.2022.05.032","article-title":"Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis","volume":"104","author":"Pan","year":"2022","journal-title":"Eur. J. Intern. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.3748\/wjg.v12.i13.2115","article-title":"Portal vein thrombosis: Prevalence, patient characteristics and lifetime risk: A population study based on 23,796 consecutive autopsies","volume":"12","author":"Ogren","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/lt.24134","article-title":"Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis","volume":"21","author":"Stine","year":"2015","journal-title":"Liver Transplant."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.cgh.2020.04.004","article-title":"Some Answers and More Questions About Portal Vein Thrombosis in Patients with Decompensated Cirrhosis","volume":"18","author":"Zanetto","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cgh.2014.10.010","article-title":"Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis","volume":"13","author":"Berry","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S1665-2681(19)31301-8","article-title":"Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis","volume":"12","author":"John","year":"2013","journal-title":"Ann. Hepatol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1148\/radiol.12112236","article-title":"Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis","volume":"265","author":"Luca","year":"2012","journal-title":"Radiology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/jhep.2003.50385","article-title":"Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators","volume":"38","year":"2003","journal-title":"Hepatology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/MEG.0b013e328357d5d4","article-title":"Splanchnic vein thrombosis and variceal rebleeding in patients with cirrhosis","volume":"24","author":"Amitrano","year":"2012","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.cgh.2020.02.037","article-title":"Prevalence and Clinical Significance of Portal Vein Thrombosis in Patients with Cirrhosis and Acute Decompensation","volume":"18","author":"Zhang","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/lt.24387","article-title":"Nontumoral portal vein thrombosis in patients awaiting liver transplantation","volume":"22","author":"Chen","year":"2016","journal-title":"Liver Transpl."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/lt.22105","article-title":"Portal vein thrombosis and liver transplant survival benefit","volume":"16","author":"Englesbe","year":"2010","journal-title":"Liver Transplant."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/TP.0000000000000785","article-title":"Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients","volume":"100","author":"Ghabril","year":"2016","journal-title":"Transplantation"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/lt.21941","article-title":"Portal vein thrombosis and survival in patients with cirrhosis","volume":"16","author":"Englesbe","year":"2010","journal-title":"Liver Transplant."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gut.2004.042796","article-title":"Splanchnic vein thrombosis in candidates for liver transplantation: Usefulness of screening and anticoagulation","volume":"54","author":"Francoz","year":"2005","journal-title":"Gut"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/TP.0b013e31826e8e53","article-title":"Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: A systematic review","volume":"94","author":"Porte","year":"2012","journal-title":"Transplantation"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MEG.0000000000000482","article-title":"Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis","volume":"28","author":"Chen","year":"2016","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1053\/j.gastro.2017.04.042","article-title":"Effects of Anticoagulants in Patients with Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis","volume":"153","author":"Loffredo","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jhep.2011.12.034","article-title":"Portal vein thrombosis, cirrhosis, and liver transplantation","volume":"57","author":"Francoz","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.32169","article-title":"Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus","volume":"75","author":"Driever","year":"2022","journal-title":"Hepatology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1148\/radiology.201.1.8816536","article-title":"Portal vein evaluation with US: Comparison to angiography combined with CT arterial portography","volume":"201","author":"Bach","year":"1996","journal-title":"Radiology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1067\/mva.2001.117331","article-title":"Acute mesenteric venous thrombosis: Case for nonoperative management","volume":"34","author":"Brunaud","year":"2001","journal-title":"J. Vasc. Surg."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00261-007-9200-x","article-title":"Portal vein thrombosis: CT features","volume":"33","author":"Lee","year":"2008","journal-title":"Abdom. Imaging"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1572-0241.2003.04020.x","article-title":"Endoscopic ultrasound is a sensitive and specific test to diagnose portal venous system thrombosis (PVST)","volume":"99","author":"Lai","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0168-8278(90)90138-H","article-title":"Natural history of hepatocellular carcinoma in Spain. Five year\u2019s experience in 249 cases","volume":"10","author":"Calvet","year":"1990","journal-title":"J. Hepatol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2217::AID-CNCR6>3.0.CO;2-M","article-title":"Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival","volume":"77","author":"Stuart","year":"1996","journal-title":"Cancer"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2214\/ajr.168.3.9057522","article-title":"Benign and malignant portal vein thrombosis: Differentiation by CT characteristics","volume":"168","author":"Tublin","year":"1997","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2214\/AJR.12.10171","article-title":"Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patients","volume":"201","author":"Sandrasegaran","year":"2013","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/lt.25345","article-title":"Distinguishing Tumor from Bland Portal Vein Thrombus in Liver Transplant Candidates with Hepatocellular Carcinoma: The A-VENA Criteria","volume":"25","author":"Sherman","year":"2019","journal-title":"Liver Transplant."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/liv.13510","article-title":"Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis","volume":"38","author":"Fortea","year":"2018","journal-title":"Liver Int."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MCG.0b013e3181b3ab44","article-title":"Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis","volume":"44","author":"Amitrano","year":"2010","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cgh.2012.01.012","article-title":"Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis","volume":"10","author":"Delgado","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3350\/cmh.2014.20.4.384","article-title":"Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: A propensity score matching analysis","volume":"20","author":"Chung","year":"2014","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/MEG.0000000000000351","article-title":"Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B","volume":"27","author":"Cui","year":"2015","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/hepr.12400","article-title":"Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis","volume":"45","author":"Naeshiro","year":"2015","journal-title":"Hepatol. Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1007\/s10620-019-05572-z","article-title":"Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis","volume":"64","author":"Reis","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41395-018-0421-0","article-title":"Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis","volume":"114","author":"Pettinari","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.clinre.2018.11.011","article-title":"Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe","volume":"43","author":"Bergere","year":"2019","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.cgh.2017.10.016","article-title":"Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis","volume":"16","author":"Braham","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejim.2014.12.002","article-title":"Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis of observational studies","volume":"26","author":"Qi","year":"2015","journal-title":"Eur. J. Intern. Med."},{"key":"ref_128","first-page":"104","article-title":"Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis: A systematic review and meta-analysis","volume":"34","author":"Ghazaleh","year":"2021","journal-title":"Ann. Gastroenterol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12325-020-01550-4","article-title":"Anticoagulation Favors Thrombus Recanalization and Survival in Patients with Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis","volume":"38","author":"Wang","year":"2021","journal-title":"Adv. Ther."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/MEG.0000000000001237","article-title":"A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis","volume":"31","author":"Vitale","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1055\/s-0040-1715473","article-title":"New Insights into the Pathogenesis, Risk Factors, and Treatment of Portal Vein Thrombosis in Patients with Cirrhosis","volume":"46","author":"Soy","year":"2020","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.cgh.2012.02.021","article-title":"Optimal length of anticoagulant therapy in cirrhotic patients with portal vein thrombosis","volume":"10","author":"Senzolo","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_133","first-page":"S201","article-title":"Anticoagulation improves overall survival through portal vein recanalization in patients with cirrhosis and portal vein thrombosis: Individual patient data meta-analysis (IMPORTAL study)","volume":"75","author":"Guerrero","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/hep.27783","article-title":"Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study","volume":"62","author":"Cerini","year":"2015","journal-title":"Hepatology"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1478-3231.2010.02358.x","article-title":"Low-molecular-weight heparin in patients with advanced cirrhosis","volume":"31","author":"Bechmann","year":"2011","journal-title":"Liver Int."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/j.1538-7836.2012.04824.x","article-title":"Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis","volume":"10","author":"Senzolo","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.pmbts.2019.02.004","article-title":"The clinical use of Fondaparinux: A synthetic heparin pentasaccharide","volume":"163","author":"Zhang","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1160\/TH07-04-0252","article-title":"Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia","volume":"99","author":"Lobo","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.amjmed.2021.05.013","article-title":"Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis","volume":"134","author":"Senzolo","year":"2021","journal-title":"Am. J. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"682","DOI":"10.4254\/wjh.v14.i4.682","article-title":"Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence?","volume":"14","author":"Biolato","year":"2022","journal-title":"World J. Hepatol."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Potze, W., Arshad, F., Adelmeijer, J., Blokzijl, H., van den Berg, A.P., Meijers, J.C., Porte, R.J., and Lisman, T. (2014). Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0088390"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/hep.27350","article-title":"Decreased in vitro anticoagulant potency of Rivaroxaban and Apixaban in plasma from patients with cirrhosis","volume":"61","author":"Potze","year":"2015","journal-title":"Hepatology"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.31264","article-title":"Mortality and Hepatic Decompensation in Patients with Cirrhosis and Atrial Fibrillation Treated with Anticoagulation","volume":"73","author":"Serper","year":"2021","journal-title":"Hepatology"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/liv.13285","article-title":"Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis","volume":"37","author":"Trebicka","year":"2017","journal-title":"Liver Int."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s10620-015-4012-2","article-title":"Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation","volume":"61","author":"Intagliata","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/ejh.12844","article-title":"The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis","volume":"98","author":"Hum","year":"2017","journal-title":"Eur. J. Haematol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/liv.14992","article-title":"Safety of direct oral anticoagulants in patients with advanced liver disease","volume":"41","author":"Semmler","year":"2021","journal-title":"Liver Int."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s11239-021-02424-4","article-title":"Safety of direct oral anticoagulants in patients with mild to moderate cirrhosis: A systematic review and meta-analysis","volume":"52","author":"Nisly","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e13397","DOI":"10.1111\/eci.13397","article-title":"Direct oral anticoagulants and advanced liver disease: A systematic review and meta-analysis","volume":"51","author":"Menichelli","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.vph.2018.05.002","article-title":"Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis","volume":"113","author":"Hanafy","year":"2019","journal-title":"Vasc. Pharmacol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/hepr.12895","article-title":"Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis","volume":"48","author":"Nagaoki","year":"2018","journal-title":"Hepatol. Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/MEG.0000000000001846","article-title":"Efficacy and safety study of direct-acting oral anticoagulants for the treatment of chronic portal vein thrombosis in patients with liver cirrhosis","volume":"32","author":"Ai","year":"2020","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1148\/radiology.186.2.8421759","article-title":"Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion","volume":"186","author":"Radosevich","year":"1993","journal-title":"Radiology"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1051-0443(98)70493-2","article-title":"Portal venous thrombosis: Percutaneous therapy and outcome","volume":"9","author":"Walser","year":"1998","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1051-0443(99)70044-8","article-title":"Symptomatic spleno-mesenteric-portal venous thrombosis: Recanalization and reconstruction with endovascular stents","volume":"10","author":"Stein","year":"1999","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/apt.15044","article-title":"Systematic review with meta-analysis: Portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis","volume":"49","author":"Rodrigues","year":"2019","journal-title":"Aliment Pharmacol. Ther."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/MEG.0000000000001219","article-title":"The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: A systematic review and meta-analysis","volume":"30","author":"Valentin","year":"2018","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.14309\/ajg.0000000000001194","article-title":"Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study","volume":"116","author":"Lv","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Zhan, C., Prabhu, V., Kang, S.K., Li, C., Zhu, Y., Kim, S., Olsen, S., Jacobson, I.M., Dagher, N.N., and Carney, B. (2021). Comparison of Non-Tumoral Portal Vein Thrombosis Management in Cirrhotic Patients: TIPS Versus Anticoagulation Versus No Treatment. J. Clin. Med., 10.","DOI":"10.3390\/jcm10112316"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1136\/gutjnl-2017-314634","article-title":"Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: A randomised controlled trial","volume":"67","author":"Lv","year":"2018","journal-title":"Gut"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1148\/radiol.15141252","article-title":"Advanced Cirrhosis Combined with Portal Vein Thrombosis: A Randomized Trial of TIPS versus Endoscopic Band Ligation Plus Propranolol for the Prevention of Recurrent Esophageal Variceal Bleeding","volume":"276","author":"Luo","year":"2015","journal-title":"Radiology"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1148\/radiol.2015150369","article-title":"Is Post-TIPS Anticoagulation Therapy Necessary in Patients with Cirrhosis and Portal Vein Thrombosis? A Randomized Controlled Trial","volume":"279","author":"Wang","year":"2016","journal-title":"Radiology"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2010.06.029","article-title":"Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis","volume":"54","author":"Han","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jvir.2014.12.012","article-title":"Portal vein recanalization-transjugularintrahepatic portosystemic shunt using the transsplenic approach to achieve transplant candidacy in patients with chronic portal vein thrombosis","volume":"26","author":"Habib","year":"2015","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jvir.2017.08.005","article-title":"Pretransplantation Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Final Analysis of a 61-Patient Cohort","volume":"28","author":"Thornburg","year":"2017","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1097\/TP.0000000000000729","article-title":"Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients with Complete Obliterative Portal Vein Thrombosis","volume":"99","author":"Salem","year":"2015","journal-title":"Transplantation"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.tvir.2016.01.006","article-title":"Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Technical Considerations","volume":"19","author":"Thornburg","year":"2016","journal-title":"Tech. Vasc. Interv. Radiol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.cgh.2021.07.018","article-title":"North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension","volume":"20","author":"Boike","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.RVI.0000156265.79960.86","article-title":"Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis","volume":"16","author":"Hollingshead","year":"2005","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.avsg.2016.06.029","article-title":"Comparison of Systemic Thrombolysis Versus Indirect Thrombolysis via the Superior Mesenteric Artery in Patients with Acute Portal Vein Thrombosis","volume":"39","author":"Liu","year":"2017","journal-title":"Ann. Vasc. Surg."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1160\/TH08-01-0015","article-title":"Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis","volume":"100","author":"Smalberg","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/liv.13728","article-title":"Low molecular weight heparin does not increase bleeding and mortality post-endoscopic variceal band ligation in cirrhotic patients","volume":"38","author":"Bianchini","year":"2018","journal-title":"Liver Int."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/MEG.0000000000001061","article-title":"Bleeding risk of variceal band ligation in extrahepatic portal vein obstruction is not increased by oral anticoagulation","volume":"30","author":"Guillaume","year":"2018","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/TP.0000000000004014","article-title":"Consensus Statement on Hemostatic Management, Anticoagulation, and Antiplatelet Therapy in Liver Transplantation","volume":"106","author":"Blasi","year":"2022","journal-title":"Transplantation"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/21\/6435\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:06:09Z","timestamp":1760144769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/21\/6435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,30]]},"references-count":174,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["jcm11216435"],"URL":"https:\/\/doi.org\/10.3390\/jcm11216435","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,30]]}}}